Back to CITADEL ADVISORS LLC

ELVN
Showing 8 of 13 quarters

Position history for CITADEL ADVISORS LLC's holdings in ENLIVEN THERAPEUTICS INC

CITADEL ADVISORS LLC holds 1.7M shares of ELVN (ENLIVEN THERAPEUTICS INC), worth $68.4M as of 2026-Q1. The position was increased (+22.4% shares). ELVN represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$68.4M

Current Shares

1.7M

Total Value Change

+$14.4M

Total Shares Change

-563,899

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
1.7M
+22.4%
$68.4M0.0%$28.75
36
2025-Q4
Increased
1.4M
+22.7%
$21.9M0.0%$15.55
34
2025-Q3
Decreased
1.2M
-21.1%
$23.8M0.0%$20.30
0
2025-Q2
Increased
1.5M
+30.9%
$29.5M0.0%$20.68
36
2025-Q1
Decreased
1.1M
-35.4%
$22.1M0.0%$21.07
0
2024-Q4
Increased
1.7M
+0.3%
$39.1M0.0%$22.39
29
2024-Q3
Decreased
1.7M
-24.9%
$44.3M0.0%$24.13
0
2024-Q2
Decreased
2.3M
-2.0%
$53.9M0.0%$23.37
0

Other major holders of ELVN: FMR LLC, Polar Capital Holdings Plc

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used